Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

FDA

FDA

11 results

Sort 11 results by:

Filter Applied. Clear All

Latest Posts

January 20, 2026 Testimony of Monique Chireau Wubbenhorst, M.D. Before the Senate HELP Committee Testimony of Monique Chireau Wubbenhorst, M.D. Before the Senate HELP Committee January 14, 2026 New Report: How Overseas Abortion Drugs Are Flooding the U.S. New Report: How Overseas Abortion Drugs Are Flooding the U.S. January 14, 2026 International Shipments of Abortion Drugs International Shipments of Abortion Drugs
Reset All Filters
FDA

We Know Shockingly Little About The Company Approved To Distribute Abortion Drugs In New Year

Few details are known about the new manufacturer expected to start selling its generic version of the abortion pill in…

charlotte-lozier-institute Charlotte Lozier Institute
January 1, 2026
Please login to bookmark Close
FDA

CLI Submits Comment Responding to Washington et al.’s Citizen Petition Requesting FDA Action on Mifepristone

In October 2025, CLI submitted a comment responding to Washington Attorney General Nicholas Brown's citizen petition submitted to the FDA,…

FDA

CLI Submits Comments to 3 Citizen Petitions Requesting FDA Action on Mifepristone

In July to August 2025, the Charlotte Lozier Institute submitted three comments responding to three citizen petitions submitted to the…

FDA

Fact Sheet: Deficiencies Affecting U.S. Abortion Data Collection and Application

This fact sheet summarizes some of the main ways U.S. abortion data, including complications and abortion-related mortality data, is currently…

FDA

The Origins and Proliferation of Unfounded Comparisons Regarding the Safety of Mifepristone

This paper systematically examines, and refutes, claims to the effect that the abortion drug mifepristone is as safe as Tylenol…

FDA

Written Testimony of Dr. Ingrid Skop on Interstate Travel for Abortion

On June 12, CLI VP of Medical Affairs Dr. Ingrid Skop testified on the issue of interstate travel for abortion…

featured-image
FDA

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article…

featured-image
FDA

New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs

A new peer-reviewed article highlights major flaws in the data used by the U.S. Food and Drug Administration (FDA) to…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image